Literature DB >> 20842743

Tricuspid annular plane systolic excursion evaluation improves selection of cardiac resynchronization therapy patients.

Francesco Cappelli1, Maria Cristina Porciani, Ilaria Ricceri, Laura Perrotta, Giuseppe Ricciardi, Paolo Pieragnoli, Giulia Paladini, Antonio Michelucci, Luigi Padeletti.   

Abstract

BACKGROUND: The beneficial effects of cardiac resynchronization therapy (CRT) on left ventricular (LV) remodeling have been extensively described. Few data are available about the effects of CRT on right ventricular (RV) function and remodeling. HYPOTHESIS: We hypothesized that CRT could also induce reverse remodeling in the right ventricle and that RV baseline functional status expressed as tricuspidal annular plane systolic excursion (TAPSE) could affect CRT response.
METHODS: Echocardiographic investigation was performed before and 6 months after CRT. In 192 patients, TAPSE, LV, and RV dimensions with functional parameters and LV dyssynchrony index were evaluated.
RESULTS: At 6 months' follow-up, 86 patients (45%) were responders to CRT according to at least 15% LV end-systolic volume reduction. Among baseline echocardiographic parameters, responders had significantly lower TAPSE, larger LV volumes, and higher LV dyssynchrony index. In responders, LV volume reduction, ejection fraction increase, and mitral regurgitation improvement were associated with RV dimensions reduction, increased TAPSE, and improved LV dyssynchrony. Receiver operating characteristic curve analysis showed that TAPSE, at 17 mm optimal cutoff, yielded 64% sensitivity and 60% specificity in predicting CRT response; similarly, LV dyssynchrony index, at 41.25 ms optimal cutoff, predicted CRT response with 60% sensitivity and 62% specificity. A subgroup analysis demonstrated that the coexistence of high TAPSE and high dyssynchrony index values increased probability of CRT response.
CONCLUSIONS: Our results show that CRT induces RV and LV reverse remodeling and that CRT patient selection can be improved by simply measuring TAPSE value.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20842743      PMCID: PMC6653600          DOI: 10.1002/clc.20806

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

Review 1.  Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?

Authors:  Jason T Rasmussen; Thenappan Thenappan; David G Benditt; E Kenneth Weir; Marc R Pritzker
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

2.  Prognostic Role of Right Ventricular Function in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.

Authors:  Antonio Rapacciuolo; Stefano Maffè; Pietro Palmisano; Anna Ferraro; Antonella Cecchetto; Antonio D'Onofrio; Francesco Solimene; Paola Musatti; Paola Paffoni; Francesca Esposito; Umberto Parravicini; Alessia Agresta; Giovanni Luca Botto; Maurizio Malacrida; Giuseppe Stabile
Journal:  Clin Cardiol       Date:  2016-07-28       Impact factor: 2.882

3.  Assessment of right ventriclular systolic function prior to cardiac resynchronization therapy: Does it make any difference?

Authors:  Mohamed A Abdelhamid; Mazen T Ghanem; Ayman M Abdelmotaleb
Journal:  Indian Heart J       Date:  2017-06-03

4.  Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy.

Authors:  Aysen Agacdiken; Umut Celikyurt; Tayfun Sahin; Kurtulus Karauzum; Ahmet Vural; Dilek Ural
Journal:  Med Sci Monit       Date:  2013-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.